Navidea Biopharmaceuticals, Inc. Navidea Biopharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • Technology
    • Overview
    • Grant Funding
  • Pipeline
  • News & Media
    • Press Releases
    • Events
    • Publications
    • In the News
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News / Events
    • Presentations
    • Overview
    • Press Releases
    • IR Calendar
    • Safe Harbor Statement
    • Email Alerts
  • Company Info
    • Overview
    • Profile
    • Management Team
    • Contacts
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Presentations
  • Overview
  • Press Releases
  • IR Calendar
  • Safe Harbor Statement
  • Email Alerts

Presentation Highlights Clinical Potential of Navidea Biopharmaceuticals’ β-Amyloid Imaging Biomarker AZD4694

May 29, 2012

Navidea Biopharmaceuticals Announces the Presentation of Data at Several Upcoming Scientific Meetings

May 9, 2012

Navidea Biopharmaceuticals Announces First Quarter 2012 Results

May 2, 2012

Navidea Biopharmaceuticals First Quarter 2012 Earnings and Business Update Conference Call Invitation

Apr 27, 2012

Navidea Biopharmaceuticals Announces Participation in Alzheimer’s Disease Scientific Meetings

Apr 25, 2012

FDA Extends PDUFA Date for Lymphoseek® by Three Months

Apr 3, 2012

Navidea Biopharmaceuticals Presents Favorable Comparison of Lymphoseek® to Sulfur Colloid at Sentinel Node Oncology Foundation and Sentinel Lymph Node Working Group

Apr 3, 2012

Navidea Biopharmaceuticals to Present at the 11th Annual Needham Healthcare Conference

Mar 29, 2012

Navidea Biopharmaceuticals Announces Presentation of Lymphoseek® Phase 3 Data at Society of Surgical Oncology Meeting

Mar 28, 2012

Navidea Announces Fourth Quarter and Full-Year 2011 Results

Feb 29, 2012
RSS
    • 1...
    • 36
    • 37
    • 38
    • 39
    • 40
    • 41
    • 42
    • 43
    • 44
    • 45
    © 2025 Navidea Biopharmaceuticals, Inc. All Rights Reserved.
    linkedin
    Privacy Policy Disclaimer Sitemap